共 50 条
- [34] Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study MEDICINA-LITHUANIA, 2023, 59 (02):
- [40] Real-World Characterization of Immune-Related Adverse Events in Nova Scotia Patients Treated with Pembrolizumab or Durvalumab and Adherence to Toxicity Management Guidelines CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2024, 77 (02):